Evidence map›Paper›PMID 37881058›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2023

Skin surface biomarkers are associated with future development of atopic dermatitis in children with family history of allergic disease.

Takahiro Sato, Janet Nikolovski, Russell Gould, Imane Lboukili, Pierre-Francois Roux, Gabriel Al-Ghalith, Jeremy Orie, Richard Insel, Georgios N Stamatas

Open access · hybridAbstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Skin surface biomarkers are associated with future development of atopic dermatitis in children with family history of allergic disease.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Takahiro SatoJanssen Research & Development, LLC, Raritan, New Jersey, USA.
Janet NikolovskiJanssen Research & Development, LLC, Raritan, New Jersey, USA.
Russell GouldJanssen Research & Development, LLC, Raritan, New Jersey, USA.
Imane LboukiliEssential Health Translational Science, Johnson & Johnson Santé Beauté France, Issy-les-Moulineaux, France.ORCID https://orcid.org/0000-0003-4964-8142
Pierre-Francois RouxEssential Health Translational Science, Johnson & Johnson Santé Beauté France, Issy-les-Moulineaux, France.
Gabriel Al-GhalithJanssen Research & Development, LLC, Raritan, New Jersey, USA.
Jeremy OrieJanssen Research & Development, LLC, Raritan, New Jersey, USA.
Richard InselJanssen Research & Development, LLC, Raritan, New Jersey, USA.
Georgios N StamatasEssential Health Translational Science, Johnson & Johnson Santé Beauté France, Issy-les-Moulineaux, France.ORCID https://orcid.org/0000-0003-4544-7597
Janssen (United States) · USJohnson & Johnson (France) · FR

Funding

Janssen Research & DevelopmentJohnson & Johnson Santé Beauté France
6 · The paper itself

Abstract

backgroundAtopic dermatitis (AD) is a common childhood chronic inflammatory skin disorder that can significantly impact quality of life and has been linked to the subsequent development of food allergy, asthma, and allergic rhinitis, an association known as the "atopic march."

objectiveThe aim of this study was to identify biomarkers collected non-invasively from the skin surface in order to predict AD before diagnosis across a broad age range of children.

methodsNon-invasive skin surface measures and biomarkers were collected from 160 children (3-48 months of age) of three groups: (A) healthy with no family history of allergic disease, (B) healthy with family history of allergic disease, and (C) diagnosed AD.

resultsEleven of 101 children in group B reported AD diagnosis in the subsequent 12 months following the measurements. The children who developed AD had increased skin immune markers before disease onset, compared to those who did not develop AD in the same group and to the control group. In those enrolled with AD, lesional skin was characterized by increased concentrations of certain immune markers and transepidermal water loss, and decreased skin surface hydration.

conclusionsDefining risk susceptibility before onset of AD through non-invasive methods may help identify children who may benefit from early preventative interventions.

Indexed as

AsthmaDermatitis, AtopicFood HypersensitivityBiomarkersChildHumansQuality of LifeBiomarkershBD-1IL-1RAIL-36γpredictive biomarkersS100A8/9

Identifiers

PMID37881058
PMCPMC10582603
OpenAlexW4387745780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.